StonvexLoading…
StonvexStonvexStonvexCore line items from PRLB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $533.13M | $500.89M | $503.88M | $488.40M |
Operating Income | $25.11M | $19.91M | $28.17M | $-97.98M |
Net Income | $21.24M | $16.59M | $17.22M | $-103.46M |
EPS (Diluted) | $0.88 | $0.66 | $0.66 | $-3.77 |
Total Assets | $763.41M | $743.51M | $772.35M | $802.17M |
Total Liabilities | $89.48M | $73.36M | $77.06M | $104.52M |
Cash & Equivalents | $110.83M | $89.07M | $83.79M | $56.56M |
Free Cash Flow OCF − CapEx | $59.66M | $68.66M | $45.16M | $40.39M |
Shares Outstanding | 23.63M | 24.23M | 25.72M | 26.89M |